Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome
about
Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancerFolliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signalingIdentification and characterization of a novel folliculin-interacting protein FNIP2Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localizationTumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signalingBirt-Hogg-Dube syndrome: clinicopathological features of the lungFrameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literatureBHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reportsGenetic and Chromosomal Aberrations and Their Clinical Significance in Renal NeoplasmsDiagnosis and management of BHD-associated kidney cancerExpression and knockdown of zebrafish folliculin suggests requirement for embryonic brain morphogenesis.Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneysDeficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasiaThe folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell developmentThe role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesisLoss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcriptionFolliculin mutations are not associated with severe COPD.The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation.Negative regulation of EGFR signalling by the human folliculin tumour suppressor proteinMolecular diagnosis and therapy of kidney cancer.The genetic basis of kidney cancer: a metabolic diseaseNon-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature10 rare tumors that warrant a genetics referral.Targeted therapies for non-clear renal cell carcinoma.Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.Characterization of pulmonary cysts in Birt-Hogg-Dubé syndrome: histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients.Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cells.Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN).Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.Human folliculin delays cell cycle progression through late S and G2/M-phases: effect of phosphorylation and tumor associated mutationsFolliculin contributes to VHL tumor suppressing activity in renal cancer through regulation of autophagy.A rare soft tissue tumor masquerading as a parathyroid adenoma in a patient with birt-hogg-dubé syndrome and multiple cervical endocrinopathies.The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytomaImpact of genetics on the diagnosis and treatment of renal cancer.Pulmonary manifestations of Birt-Hogg-Dubé syndrome.Advances in the genetics of familial renal cancerThe folliculin mutation database: an online database of mutations associated with Birt-Hogg-Dubé syndromeRenal cancer and pneumothorax risk in Birt-Hogg-Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD familiesFamilial renal cancer: molecular genetics and surgical management.
P2860
Q24298712-DC6A54C1-EA55-4368-B421-FF1B047598F6Q24306277-91A2BE19-EE0E-4BBB-AD77-E351DFCBB77BQ24318963-E221151C-7F68-4CD8-9E07-5C8AAA5916A5Q24324012-8A1252C9-B3CE-49E6-A92D-354A0EE93A9DQ24329165-EEE754C4-6698-4A04-BE50-A620823B8DE7Q24606257-12B5D208-F789-4A79-84FC-0F19CF42FE3DQ24623891-4FB6B2D7-5C24-4414-A122-351D8C390886Q24654382-5C79D6C6-1E70-46E1-9754-55A559DC9AC4Q26785930-4AC90749-7673-4898-AB63-2BF74DB0C1E5Q26822677-CDFD1826-E3EB-491F-80A0-9BE486D54CD8Q27318467-1EAC29B6-7DAE-4D77-8760-DB5EE8FA2811Q28513499-E15A02F8-9FB4-416C-AB3C-63917742E998Q28587662-22043EEE-9477-4293-879C-6F5DB87B3BA5Q28587887-54698714-259E-4047-8DA8-C3CA5FF3AABDQ28590041-75EF7357-D70E-453F-8E57-D3DA2D97E4B0Q28595056-7A584740-52FA-4062-B538-94729CFCD1E1Q33396563-8D296D82-B7BC-4539-A7F1-66B7C0919FC9Q33685916-5A468280-8B03-444E-86D1-ABEBD43E1BC7Q33861388-096C3595-69F8-4A19-BE01-800AA573DE67Q34065685-7D59BBF9-3204-4A4B-AF13-8AB7050D5B5CQ34087148-1C9C6077-A258-4E01-B536-E67D5738FB41Q34194075-3B393584-561D-47BE-B462-3D41AF66633CQ34308406-35F617F8-51F7-44F6-BDEB-D822579FA6E2Q34325954-304501F7-50D4-4F8A-ABD6-E3EAAAD2CBEEQ34412479-27B39427-8E4E-4410-8056-69E36985E6DEQ34447213-24432F00-0C79-448E-BC31-ACE91366FAD6Q34541274-BDD0E71D-E87E-4442-B2F5-0E3552613C47Q34582386-14363B53-E730-4512-9A12-703413016E49Q34589207-943919FC-814B-452A-9BBE-B0FC3EB53C42Q34785861-A2B379A9-02C0-4956-98F7-A8EC1458B89BQ34846527-AE146E7E-2962-43B4-B34F-9EC33B99D6D5Q34905447-4177DEED-A06F-4B9B-8C48-FF86E0D6C6F2Q34913413-4258C5C0-5316-4795-9C1D-56917B06598FQ35189567-03FB8718-A1FC-4B6E-A07C-0BE409B5947FQ35189579-156C9EAC-523B-4A0E-AE75-53717C82AF61Q35536837-4346D05C-E76D-4E7E-A394-65EDB9063383Q35584092-EE906682-6328-48AD-A4CD-AA3EB9160658Q35602650-563F9200-508C-4944-A263-839902F09C8EQ35653949-ABACE6CC-457C-4541-8A56-5385BBE0DB84Q35687676-64EBFCEE-BD57-4925-B835-20A6DCD658C3
P2860
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@ast
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@en
type
label
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@ast
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@en
prefLabel
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@ast
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@en
P2093
P2860
P356
P1476
Germline BHD-mutation spectrum ...... s with Birt-Hogg-Dubé syndrome
@en
P2093
Berton Zbar
Eamonn R Maher
Gladys M Glenn
James Peterson
Jorge R Toro
Laura S Schmidt
Maria J Merino
Maria L Turner
McClellan M Walther
Michael L Nickerson
P2860
P304
P356
10.1086/430842
P407
P577
2005-04-25T00:00:00Z